Introduction
Growth hormone (GH) can promote testicular growth and function in animals with inherited or experimentally induced GH deficiency (Bartke, 1965; Zipf et ai, 1978) and appears to play a role in male puberty (Handelsman et ai, 1987; Al-Haboby et ai, 1988) . However, high concentrations of GH in acromegalie patients and in transgenic boars is associated with reduced libido (Jadresic et ai, 1982; Pinkert et ai, 1991) and there is evidence for suppression of testicular development and function in transgenic boars and rams expressing heterologous GH genes (Pinkert et ai, 1991; Rexroad, 1991) . Expression of various GH genes in transgenic mice is often associated with greatly reduced reproductive performance (Hammer et ai, 1984; Yun& Wagner, 1987; Bartke et ai, 1988) . However, transgenic male mice that express experimentally introduced GH genes and exhibit phenotypic consequences of high GH, but are fertile and transmit the heterologous gene to their progeny, have been produced in several laboratories (Hammer et ai, 1984; McGrane et ai, 1988; Seiden et ai, 1988 Seiden et ai, , 1989 . Indeed, most, if not all, currently available established lines of GH-expressing transgenic mice are routinely maintained by crossing transgenic males with normal females.
In the course of studies of the hypothalamic-pituitary-gonadal axis in four lines of transgenic mice expressing human or bovine GH genes (Bartke et ai, 1988 (Bartke et ai, , 1990 Steger et ai, 1991) , we noticed a high incidence of male sterility in one of the lines and loss of fertility at an abnormally early age in this and in two other lines. We therefore decided to obtain quantitative evaluation of sperm production and male reproductive performance in these animals. The characteristics of the lines examined in terms of their origin, developmental stages at the onset of hybrid-gene expression and plasma concentrations of heterologous GH, as well as differences between the actions of human (h)GH and bovine (b)GH in mice were discussed previously Naareta/., 1991; Steger et ai, 1991) .
Materials and Methods

Animals
We examined transgenic male mice with the following gene constructs: (i) mouse metallothionein-I/human GH (MT/hGH); (ii) MT/human placental GH'B' variant (MT/hGH-V); (iii) MT/bovine GH (MT/bGH); and (iv) phosphoenolpyruvate carboxykinase/bGH (PEPCK/bGH).
The production and initial characterization of these lines with respect to, for example, somatic growth, sites of transgene expression and female reproductive functions have been described previously (McGrane et ai, 1988; Seiden et ai, 1988 Seiden et ai, , 1989 Mayerhofer et ai, 1990; Naar et ai, 1991) . The animals used for the present study were produced by crossing transgenic males with C57BL/6 x C3H F, hybrid females purchased from the Jackson Laboratory (Bar Harbor, ME, USA). The animals were housed in a room with controlled photoperiod (12 h Organs and sperm production Three-and-a-half weeks after the start of this experiment, the males were killed by decapitation. Trunk blood was collected for measurements of glucose (Sigma kit: Sigma, St Louis, MO, USA), the testes and epididymides were removed and immediately frozen for subsequent determination of numbers of testicular spermatids, daily sperm production, numbers of epididymal spermatozoa and transit time. The weights of various reproductive and nonreproductive organs were recorded, because this information has not been reported before for most of the lines used. In an attempt to distinguish between hypertrophy and hyperplasia, the contents of protein and DNA in the liver, heart and kidney were determined using procedures described by Bradford (1976) and Burton (1956) , respectively. (Yun & Wagner, 1987; Bartke et ai, 1988; McGrane et ai, 1988; Seiden et ai, 1988 Seiden et ai, , 1989 Cecim, 1990; Cecim et Daily sperm production and numbers of epididymal spermatozoa were determined in another group of 16 MT/hGH transgenic males and 15 nontransgenic siblings of these animals. All these animals were 10-14 weeks old, had never been used for breeding and were group-housed until they were killed.
For counting the spermatids, the frozen testes were thawed, weighed, decapsulated and homogenized for 2 min in a Waring blender in 100 ml of fluid containing 150 mmol NaCl \ 003% v/v Triton X-100, and 3-8 mmol NaN3 1" ' in water (Amann & Lambíase, 1969) . Homogenization-resistant spermatids were counted by phase-contrast cytometry as described by Amann et cd. (1976) and Johnson & Neaves (1983) . On the basis of their morphology and chromatic condensation, spermatids that survive homogenization correspond to maturation-phase spermatids (steps [14] [15] [16] ) that occur in stages II VIII in mice (Oakberg, 1956a, b) . Since these stages have a total duration of 4-84 days of a cycle of 8-63 days, the daily sperm production per testis was calculated by dividing the number of maturation-phase spermatids in the homogenates by the estimated lifespan of these spermatids (4-84 days). The number of spermatozoa in the epididymis was determined in epididymal homogenates prepared as described for the testis (Johnson & Varner, 1988) . Epididymal transit time was determined by dividing the number of sperm in the epididymis by daily sperm production of the ipsilateral testis from the same animal (Amann et ai, 1976; Johnson & Varner, 1988 (Table 2 ). In contrast, only two of seven MT/hGHV males and two of six MT/hGH males proved to be fertile (P < 005 versus nontransgenic controls). The proportion of females that became pregnant after cohabiting for one week with a fertile male was significantly lower than normal in matings with transgenic MT/hGH males (Table 2) . Among females mated to MT/hGH-V transgenic males, the proportion of females that had a vaginal plug and became pregnant was also significantly lower (P < 001). The net effect of these differences was a significantly lower proportion of females becoming pregnant after cohabiting for one week with a transgenic MT/hGH, MT/hGH V or PEPCK/bGH male (Table 2) , but the proportion becoming pregnant after cohabiting with a MT/bGH transgenic male was not affected. 12-5 + 0-5 13-6 + 0-7 13-6 + 0-9 Mean number of fetuses 13-4 + 0-5 14c 14-5 + 0-5 12-7 + 0-7 13-7 + 0-8 Mean number of live fetuses 13-3 + 0-6 13c 14-0 + 0-0 12-4 + 0-6 13-1+0-8 aDifferent from normal controls, < 005. bDifferent from normal controls, < 0001.
Only one female was autopsied.
Data are means + sem.
Examination of females on day 14 of pregnancy revealed no differences between those mated to various transgenic or normal males in terms of the numbers of corpora lutea, or total and live fetuses or proportion of corpora lutea represented by fetuses (Table 2) .
Body weight of transgenic males was significantly greater than normal in every line, as expected (Table 3) . Analysis of autopsy data revealed that testicular weight did not increase in proportion to body weight. Thus, although the absolute weight of the testis was greater in transgenic males from every line examined, the relative weight of the testis was either unaltered (MT/hGH and MT/bGH) or significantly lower (MT/hGHV and PEPCK/bGH). Absolute weight of the seminal vesicles was greater in each type of transgenic male examined, but the relative weight of the seminal vesicles was significantly greater only in males expressing human GH genes (hGH or hGH-V). The absolute weight of the liver was much higher in all transgenic males and the relative weight of the liver was significantly greater, except for the MT/hGH males. Both the absolute and the relative weights of the spleen were greater in MT/hGH-V and PEPCK/bGH transgenic males than in normal males. Absolute weights of the adrenals and the heart were significantly greater in each of the four types of transgenic males. The apparent increases in the absolute weights of the thymus and the kidney were significant in only some of the lines, apparently as a result of greater variance of these measures. The relative weights of the thymus, the adrenals, the heart and the kidney did not differ between the normal and transgenic males (data not shown). There were no differences between normal and transgenic males in the concentration of DNA in the liver (data not shown). Protein concentration (pg protein mg~' wet weight) was significantly lower in the livers of PEPCK/bGH males and not altered in males from the remaining three lines (Table 3 ). There were no differences between the normal and the transgenic males (from any of the four lines examined) in the protein concentration in the kidney and the heart, or in protein:DNA ratios in the liver, kidney and heart (data not shown).
Plasma glucose concentration was significantly greater in PEPCK/bGH males than in normal males and appeared to be similarly altered in MT/bGH males ( When daily sperm production and epididymal sperm reserves were examined in a larger number of transgenic MT/hGH and normal (nontransgenic) males, the results were similar. Thus, sperm production per testis was significantly greater, but sperm production g~' of testis was not altered, in transgenic males (Table 5) . However, epididymal content of spermatozoa was significantly greater in this group of younger transgenic animals, which had not been used for breeding. The reasons for reduced fertility of MT/hGH and MT/hGH-V transgenic males are not readily apparent from quantitative assessment of spermatogenesis or from the analysis of autopsy data. The only characteristic that appeared to distinguish transgenic mice expressing hGH genes from those expressing the bGH gene was a greater proportional increase in the weight of the seminal vesicles in the former. Increased weight of the seminal vesicles and the coagulating glands in adult transgenic MT/hGH and MT/hGHV males is associated with massive hypertrophy of these organs later in life (Cecim et ai, 1990) and is thought to be due to lactogenic activity of hGH and hGH-V molecules in mice (Forsyth et ai, 1965; Bartke et ai, 1990; Nickel et ai, 1990) . However, it is not obvious how excessive stimulation of the growth and secretory activity of male accessory reproductive glands would compromise fertility, particularly in animals studied several months before the onset of gross enlargement of these organs.
Comparisons of organ weights, daily sperm production and epididymal sperm content between males that did and those that did not sire litters within each line did not reveal any significant differences or consistent trends.
Thus, reasons for reduced reproductive performance of MT/hGH and MT/hGHVmales remain to be elucidated. Secondary sterility of 12-15-month-old MT-hGH males appears to be due to difficulties in gaining intromission and inability to inseminate females without loss of libido, as assessed from mount latencies (Bartke et ai, 1991) . However, our preliminary studies did not reveal differences in mount latency, intromission latency or other measures of copulatory behaviour between fertile and sterile MT/hGH-V transgenic males tested with ovariectomized females brought into behavioural oestrus by injections of oestradiol and progesterone (A. Bartke and D. Mayerhofer, unpublished observations) .
In females examined 14 days after mating with transgenic males, no abnormalities were apparent in mortality before or after implantation or in the number of fetuses. Examination of other normal females mated to transgenic males from the same lines (Naar et ai, 1991) (Bartke et ai, 1988 (Bartke et ai, , 1990 Chandrashekar et ai, 1988; Steger et ai, 1990 Steger et ai, , 1991 as well as in the control of testicular LH receptors (Amador et ai, 1990) , transgenic males are not androgen deficient. This conclusion is based on measurements of plasma testosterone concentration and testosterone pro¬ duction in vitro under basal conditions and after stimulation with human chorionic gonadotrophin (Chandrashekar et ai, 1988; Amador et ai, 1990; A. Bartke, A. Lingle & D. Schultz, unpublished observations) and is consistent with data on the weight of androgen-dependent organs.
Nonomura et ai (1985) reported low fertility in C57BL/6 males with long-term (16 weeks) experimentally induced hyperprolactinaemia. In the present study, low fertility was noted in males producing human growth hormones that are lactogenic in mice (Forsyth et ai, 1965; Seiden et ai, 1988; Bartke et ai, 1990) and not in those expressing bGH genes. Berger et al. (1989) reported reductions in absolute testis weight and in fertility in one of two lines of mice selected for high adult body weight as a result of high growth after weaning, but no information is available on the possible endocrine correlates of these findings.
Low fertility in transgenic mice should probably not be considered as premature reproductive ageing. Fertility in the various lines did not correlate with lifespan (Table 1) , and data from our breeding colony indicated that a high incidence of male infertility in MT/hGH-males was evident at the age of 2-3 months. The low reproductive performance of transgenic males may have been due to insertional mutagenesis.
In the lines of transgenic MT/hGH, MT/hGH-V, MT/bGH and PEPCK/bGH mice examined in the present study, male reproductive performance did not correlate with reproductive performance of transgenic females from the same lines (Naar et ai, 1991) . Presumably, reproductive abnormalities in both sexes are due to different mechanisms.
Differences in body and organ weights between transgenic and normal mice in the present study were generally consistent with the previously described consequences of ectopie expression of various GH genes in mice with MT and PEPCK promoters (Hammer et ai, 1984; Shea et ai, 1987; Cecim, 1990) and particularly with the results of analysis of growth allometry in MT/rGH and MT/bGHmice (Shea et ai, 1987; Cecim, 1990) . Thus, adult body weight of transgenic animals was approximately 50% greater than normal in each of the lines. Differences between normal and transgenic mice in weights of organs such as heart, kidney, thymus and adrenal gland were proportional to differences in body weight. Differences in the weights of the liver and spleen in some of the lines were greater and the weights of the testis were generally less than in proportion to the difference in adult body weight. These results agree with the previous report of growthpromoting activity of the hGH-V gene in the same line of transgenic mice (Seiden et ai, 1988) (Matthews et ai, 1988) . Lack of differences between transgenic and normal males in the protein: DNA ratios in the liver, heart and kidney suggests that the size of these organs in transgenic mice was increased primarily by hyperplasia. Normal concentration of protein in these organs, with the exception of livers in PEPCK/bGH males, tends to support this conclu¬ sion. However, the effects of transgene expression on endomitosis or incidence of polyploidy have not been evaluated. Low protein concentration in the livers of transgenic PEPCK/bGH males probably reflects greater lipid content in the livers of these animals. This conclusion is supported by gross observations of liver histology in transgenic animals of this strain (M. Cecim, unpublished observations).
High concentration of glucose in plasma of PEPCK/bGH males that have very high concen¬ trations of circulating GH is consistent with the well-documented 'diabetogenic' action of this hormone (Daughaday, 1985) , although McGrane et ai (1990) did not detect altered serum glucose concentration in PEPCK/bGH transgenic mice.
In the lines of transgenic mice examined in the present study, expression of human GH genes was associated with significant reduction in fertility, whereas expression of the bGH gene was compatible with normal reproductive performance. Reduced fertility MT/hGH and MT/hGHV transgenic males was not associated with any defects in numbers of testicular or epididymal sperm or with gross abnormalities of the male reproductive system and was due mainly to significantly reduced ability to inseminate females during a standardized period of exposure. In females impreg¬ nated by these males, fertilization rate, embryo survival and fetal growth appeared to be normal, at least during the first 2 weeks of pregnancy. Thus, ectopie production of hormones that bind to GH and prolactin receptors in transgenic mice interferes with male fertility via mechanisms that remain to be elucidated. In contrast, chronic excess of bGH, which is 'purely' somatotrophic in rodents, has little, if any, effect on male reproductive performance.
